DeDora Capital Inc. purchased a new stake in CME Group Inc (NASDAQ:CME) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,438 shares of the financial services provider’s stock, valued at approximately $730,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Dubuque Bank & Trust Co. grew its holdings in shares of CME Group by 83.1% during the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 69 shares in the last quarter. Resources Investment Advisors Inc. boosted its holdings in CME Group by 2,800.0% in the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares in the last quarter. Ruggie Capital Group bought a new stake in CME Group in the fourth quarter worth $28,000. Smith Asset Management Group LP boosted its holdings in CME Group by 200.0% in the fourth quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 100 shares in the last quarter. Finally, Truvestments Capital LLC bought a new stake in CME Group in the first quarter worth $32,000. 84.72% of the stock is currently owned by institutional investors.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $168.27, for a total transaction of $420,675.00. Following the completion of the transaction, the chief financial officer now owns 35,354 shares of the company’s stock, valued at $5,949,017.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kathleen M. Cronin sold 8,340 shares of the company’s stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $167.54, for a total transaction of $1,397,283.60. Following the transaction, the insider now directly owns 41,604 shares of the company’s stock, valued at approximately $6,970,334.16. The disclosure for this sale can be found here. Insiders have sold 28,489 shares of company stock valued at $4,948,996 in the last ninety days. 1.20% of the stock is owned by company insiders.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, beating the Zacks’ consensus estimate of $1.60 by $0.02. The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.86 earnings per share. As a group, equities analysts anticipate that CME Group Inc will post 6.62 EPS for the current fiscal year.
CME has been the subject of a number of recent research reports. JPMorgan Chase & Co. decreased their price objective on shares of CME Group from $164.00 to $150.00 and set an “underweight” rating for the company in a report on Friday, March 22nd. BidaskClub cut shares of CME Group from a “hold” rating to a “sell” rating in a report on Wednesday, February 20th. Deutsche Bank decreased their price objective on shares of CME Group from $220.00 to $214.00 and set a “buy” rating for the company in a report on Friday, March 15th. Bank of America reiterated a “neutral” rating and issued a $191.00 price objective (down from $200.00) on shares of CME Group in a report on Friday, January 11th. They noted that the move was a valuation call. Finally, Rosenblatt Securities cut shares of CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. CME Group presently has a consensus rating of “Hold” and an average target price of $189.71.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: Mutual Funds
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.